Advertisement
Health News | Avatar Posted by ffnstuff 32 days ago (http://www.medicalnewstoday.com)
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Amgen (NASDAQ:AMGN) announced the publication of data from the COMET (COmbination of Methotrexate and ETanercept in Active Early Rheumatoid Arthritis) trial demonstrating that half of patients treated with the combination of ENBREL and metho
Discuss   Share This  Tell a friend   Discard


Comments Who Ranked Related Links

Quick Guide
Home
Submit
Sign Up
About, Contact
Blog, Health Ranker on Twitter
Privacy Policy, Terms of Use

© 2008 HealthRanker.com | User-submitted content is licensed under a Creative Commons Public Domain License.
Disclaimer: The information found on Health Ranker user-submitted pages is from various websites, thus the reliability of the information cannot be vouched for.
Health Ranker is for informational purposes only. We do not provide medical or any other health care advice, diagnosis or treatment.
The information provided is designed to support, not replace, the relationship that exists between a patient and his/her physician.